Studies from this laboratory have led to a unifying hypothesis of body fluid volume regulation. This hypothesis emphasizes the importance of the integrity of the arterial circulation as the primary determinant of renal sodium and water excretion and thus body fluid volume regulation. An impairment in arterial circulatory integrity, so-called arterial underfilling, can be mediated by either a decrease in cardiac output or peripheral arterial vasodilation. We have proposed that two important clinical states, namely pregnancy and cirrhosis, are associated with arterial underfilling resulting from primary peripheral arterial vasodilation. In support of this hypothesis are associated hemodynamic, hormonal and renal excretory characteristics of pregnancy and cirrhosis which can be mimicked by arterial vasodilation. These include increased cardiac output secondary to afterload reduction; decreased mean arterial pressure secondary to primary arterial vasodilation; stimulation of the neurohumoral response to arterial underfilling including activation of the renin-angiotensin-aldosterone axis, the sympathetic nervous system and the non-osmotic release of vasopressin; and renal sodium and water retention. Pivotal to this arterial vasodilation hypothesis is the identification of the specific vasodilator(s) that may occur in pregnancy and cirrhosis. The quantification of the role of any vasodilator must them be assessed by examining the hemodynamic, humoral and renal alterations which occur in association with blockade of the specific vasodilator. In the present study research protocols have been designed to evaluate the role of nitric oxide in the peripheral arterial vasodilation associated with pregnancy and cirrhosis. Preliminary results from our laboratory and others suggest the possibility that nitric oxide may be a major mediator of the arterial vasodilation in pregnancy and cirrhosis. Different convergent methods will be used to evaluate this possibility and, if confirmed, to study the factors responsible for an activation or induction of nitric oxide synthase. Chronic oral blockage of nitric oxide production by a L-arginine competitive antagonist (nitro-L -arginine methylester) will be used in pregnant and cirrhotic rats to test the role of nitric oxide. Based on our body fluid volume regulatory hypothesis, the hemodynamic, renal and hormonal modifications observed in these states should be reversed, at least in part by nitric oxide blockade. In vitro vascular studies and molecular biology techniques will be used to confirm the activation or induction of the nitric oxide synthase. Other potential vasoactive substance sin cirrhosis will also be investigated using IL-1 receptor antagonists, endothelin antagonists and bradykinin antagonists.

Project Start
Project End
Budget Start
Budget End
Support Year
16
Fiscal Year
1994
Total Cost
Indirect Cost
Name
University of Colorado Denver
Department
Type
DUNS #
065391526
City
Aurora
State
CO
Country
United States
Zip Code
80045
Li, Chunling; Wang, Weidong; Rivard, Christopher J et al. (2011) Molecular mechanisms of angiotensin II stimulation on aquaporin-2 expression and trafficking. Am J Physiol Renal Physiol 300:F1255-61
Andres-Hernando, Ana; Lanaspa, Miguel A; Li, Nanxing et al. (2010) Effects of 2-bromoethanamine on TonEBP expression and its possible role in induction of renal papillary necrosis in mice. Toxicol Sci 118:510-20
Furgeson, Seth B; Simpson, Peter A; Park, Insun et al. (2010) Inactivation of the tumour suppressor, PTEN, in smooth muscle promotes a pro-inflammatory phenotype and enhances neointima formation. Cardiovasc Res 86:274-82
Wang, Weidong; Li, Chunling; Summer, Sandra et al. (2010) Interaction between vasopressin and angiotensin II in vivo and in vitro: effect on aquaporins and urine concentration. Am J Physiol Renal Physiol 299:F577-84
Schrier, Robert W (2010) Systemic arterial vasodilation, vasopressin, and vasopressinase in pregnancy. J Am Soc Nephrol 21:570-2
Lanaspa, Miguel A; Andres-Hernando, Ana; Rivard, Christopher J et al. (2009) ZAC1 is up-regulated by hypertonicity and decreases sorbitol dehydrogenase expression, allowing accumulation of sorbitol in kidney cells. J Biol Chem 284:19974-81
Schrier, Robert W (2009) Interactions between angiotensin II and arginine vasopressin in water homeostasis. Kidney Int 76:137-9
Berl, Tomas (2009) How do kidney cells adapt to survive in hypertonic inner medulla? Trans Am Clin Climatol Assoc 120:389-401
Bansal, Shweta; Lindenfeld, JoAnn; Schrier, Robert W (2009) Sodium retention in heart failure and cirrhosis: potential role of natriuretic doses of mineralocorticoid antagonist? Circ Heart Fail 2:370-6
Schrier, Robert W; Masoumi, Amirali; Elhassan, Elwaleed (2009) Role of vasopressin and vasopressin receptor antagonists in type I cardiorenal syndrome. Blood Purif 27:28-32

Showing the most recent 10 out of 153 publications